Physicochemical optimisation of plasmid delivery by cationic lipids

Journal of Gene Medicine

Volumn 6, Issue SUPPL. 1, 2004, Pages

  Tranchant, Isabelle ^a   Thompson, Betty ^a   Nicolazzi, Céline ^a   Mignet, Nathalie ^a   Scherman, Daniel ^a  

^a CNRS   (France)

Author keywords

Cationic lipids; Gene therapy; Liposomes; Non viral vectors

Indexed keywords

ALCOHOL; CHLOROQUINE; DEOXYRIBONUCLEASE; IMIDAZOLE; LIPID; LIPOFECTAMINE; LIPOPLEX; LIPOSOME; LUCIFERASE; MACROGOL; PHOSPHATIDYLETHANOLAMINE; PLASMID DNA; PLASMID VECTOR; PROTAMINE; VIRUS VECTOR; DETERGENT; SOLVENT;

BIOAVAILABILITY; CELL STRAIN COS7; CYTOTOXICITY; DNA BINDING; ENCAPSULATION; ENDOCYTOSIS; ENZYME DEGRADATION; GENE TARGETING; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION; TISSUE INTERACTION; ANIMAL; CELL STRAIN 3T3; GENE TRANSFER; MOUSE; PLASMID;

ANIMALS; DETERGENTS; ETHANOL; GENE TRANSFER TECHNIQUES; LIPIDS; LIPOSOMES; MICE; NIH 3T3 CELLS; PLASMIDS; SOLVENTS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 3242746274     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.509     Document Type: Review

References (83)

1. See the excellent reviews published in Curr. Med. Chem. 2003; 10: 1185-1315.
2. Boggs J and Hsia J. Effect of cholesterol and water on the rigidity and order of phosphatidylcholine bilayers. Biochim Biophys Acta 1972; 290: 32-42.
3. Floch V, Loisel S, Guenin E, et al. Cation substitution in cationic phosphonolipids: a new concept to improve transfection activity and decrease cellular toxicity. J Med Chem 2000; 43: 4617-4628.
4. Ferrari M, Rusalov D, Enas J, et al. Synergy between cationic lipid and co-lipid determines the macroscopic structure and transfection activty of lipoplexes. Nucleic Acids Res 2002; 30 1808-1816.
5. Niculescu-Duvaz D, Heyes J, Springer C. Structure-activity relationship in cationic lipid mediated gene transfection. Curr Med Chem 2003; 10: 1233-1261.
6. Herscovici J, Egron M, Quenot A, et al. Synthesis of new cationic lipids from an unsaturated glycoside scaffold. Org Lett 2001; 3: 1893-1896.
7. Felgner PL, Gadek TR, Holm M, et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A 1987; 84: 7413-7417.
8. Leventis R, Silvius J. Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles. Biochim Biophys Acta 1990; 1023: 124-132.
9. Gao X, Huang L. Cationic liposome-mediated gene transfer. Gene Ther 1995; 2: 710-722.
10. Behr JP, Demeneix B, Loeffler JP, et al. Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. Proc Natl Acad Sci U S A 1989; 86: 6982-6986.
11. Byk G, Dubertret C, Escriou V, et al. Synthesis, activity, and structure-activity relationship studies of novel cationic lipids for DNA transfer. J Med Chem 1998; 41: 224-235.
12. Even-Chen S, Barenholtz Y. DOTAP cationic liposomes prefer relaxed over supercoiled plasmids. Biochim Biophys Acta 2000; 1509: 176-188.
13. Miller A. Cationic liposomes for gene therapy. Angew Chem 1998; 41: 1768-1785.
14. Marshall J, Nietupski J, Lee E, et al. Cationic lipid structure and formulation considerations for optimal gene transfection of the lung. J Drug Target 2000; 7: 453-469.
15. Alton E, Middleton P, Caplen N, et al. Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nat Genet 1993; 5: 135-142.
16. Vigneron JP, Oudrhiri N, Fauquet M, et al. Guanidinium-cholesterol cationic lipids: efficient vectors for the transfection of eukaryotic cells. Proc Natl Acad Sci U S A 1996; 93: 9682-9686;
17. Densmore C, Giddings T, Waldrep J, et al. Gene transfer by guanidinium-cholesterol: dioleoylphosphatidyl-ethanolamine liposome-DNA complexes in aerosol. J Gene Med 1999; 1: 251-264;
18. Pitard B, Oudrhiri N, Lambert O, et al. Sterically stabilized BGTC-based lipoplexes: structural features and gene transfection into the mouse airways in vivo. J Gene Med 2001; 3 478-487.
19. Heyes J, Niculescu-Duvaz D, Cooper R, et al. Synthesis of novel cationic lipids: effect of structural modification on the efficiency of gene transfer. J Med Chem 2002; 45: 99-114.
20. Budker V, Gurevich V, Hagstrom JE, et al. pH-sensitive, cationic liposomes: a new synthetic virus-like vector. Nat Biotechnol 1996; 14: 760-764.
21. Remy J, Sirlin C, Vierling P, et al. Gene transfer with a series of lipophilic DNA-binding molecules. Bioconjug Chem 1994; 5: 647-654.
22. Uchida E, Mizuguch H, Ishii-Watabe A, et al. Comparison of the efficiency and safety of non-viral vector-mediated gene transfer into a wide range of human cells. Biol Pharm Bull 2002; 25: 891-897.
23. Zemlinska B, Sochanik A, Missol-Kolka E, et al. Various cationic carriers for in vitro transfection of tumor and endothelial cell lines. Acta Biochim Pol 2002; 49: 285-290.
24. Aujame L, Seguin D, Droy C, et al. Experimental design optimization of filamentous phage transfection into mammalian cells by cationic lipids. Biotechniques 2000; 28: 1202-1206.
25. Plank C, Mechtler K, Szoka FC Jr, et al. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum Gene Ther 1996; 7: 1437-1446.
26. Bangham A, Standish M, Watkins J. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 1965; 13: 238-252.
27. Kremer J, Esker M, Pathmamanoharan C, et al. Vesicles of variable diameter prepared by a modified injection method. Biochemistry 1977; 16: 3932-3935.
28. Szoka F, Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse phase evaporation. Proc Natl Acad Sci U S A 1978; 75: 4194-4198.
29. Felgner J, Kumar R, Sridhar C, et al. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem 1994; 269: 2550-2561.
30. Domazou A, Luigi Luisi P. Size distribution of spontaneously formed liposomes by the ethanol injection method. J Liposome Res 2002; 12: 205-220.
31. Ferrari M, Rusalov D, Enas J, et al. Trends in lipoplex physical properties dependent on cationic lipid structure, vehicle and complexation procedure do not correlate with biological activity. Nucleic Acids Res 2001; 29: 1539-1548.
32. Pitard B, Aguerre O, Airiau M, et al. Virus-sized self-assembling lamellar complexes between plasmid DNA and cationic micelles promote gene transfer. Proc Natl Acad Sci U S A 1997; 94: 14 412-14 417.
33. Eastman S, Siegel C, Tousignant J, et al. Biophysical characterization of cationic lipid: DNA complexes. Biochim Biophys Acta 1997; 1325: 41-62.
34. Rädler J, Koltover I, Salditt T, et al. Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes. Science 1997; 275: 810-814.
35. Koltover IT, Radler J, Safinya C. An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. Science 1998; 281: 78-81.
36. Zelphati O, Szoka F. Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids. Pharm Res 1996; 13: 1367-1372.
37. Turek J, Dubertret C, Jaslin G, et al. Formulations which increase the size of lipoplexes prevent serum-associated inhibition of transfection. J Gene Med 2000; 2: 32-40.
38. Koltover I, Salditt T, Safinya C. Phase diagram, stability, and overcharging of lamellar cationic lipid-DNA self-assembled complexes. Biophys J 1999; 77: 915-924.
39. Raspaud E, Pitard B, Durand D, et al. Polymorphism of DNA/multicationic lipid complexes driven by temperature and salts. J Phys Chem B 2001; 105: 5291-5297.
40. Templeton N, Lasic D, Frederik P, et al. Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat Biotechnol 1997; 15: 647-652.
41. Allen T, Cleland L. Serum-induced leakage of liposome contents. Biochim Biophys Acta 1980; 597: 418-426.
42. Li S, Huang L. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther 1997; 4: 891-900.
43. Baraldo K, Leforestier N, Bureau M, et al. Sphingosine-based liposome as DNA vector for intramuscular gene delivery. Pharm Res 2002; 19: 1143-1148.
44. Escriou V, Ciolina C, Lacroix F, et al. Cationic lipid-mediated gene transfer: effect of serum on cellular uptake and intracellular fate of lipopolyamine/DNA complexes. Biochim Biophys Acta 1998; 1368: 276-288.
45. Shi G, Guo W, Stephenson SM, et al. Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations. J Control Release 2002; 80: 309-319.
46. Byk G, Wetzer B, Frederic M, et al. Reduction-sensitive lipopolyamines as a novel nonviral gene delivery system for modulated release of DNA with improved transgene expression. J Med Chem 2000; 43: 4377-4387;
47. Wetzer B, Byk G, Frederic M, et al. Reducible cationic lipids for gene transfer. Biochem J 2001; 356: 747-756;
48. Tang F, Wang W, Hughes JA. Cationic liposomes containing disulfide bonds in delivery of plasmid DNA. J Liposome Res 1999; 9: 331-347.
49. Mignet N, Byk G, Wetzer B, et al. DNA complexes with reducible cationic lipid for gene transfer. Methods Enzymol. 2003; 373: in press.
50. Templeton N. Cationic liposomes as in vivo delivery vehicles. Curr Med Chem 2003; 10: 1279-1287.
51. Zelphati O, Nguyen C, Ferrari M, et al. Stable and monodisperse lipoplex formulations for gene delivery. Gene Ther 1998; 5: 1272-1282.
52. Li B, Li S, Tan Y, et al. Lyophilisation of cationic lipid-protamine-DNA (LPD) complexes. J Pharm Sci 2000; 89: 355-364.
53. Faneca H, Simoes S, de Lima M. Evaluation of lipid-based reagents to mediate intracellular gene delivery. Biochim Biophys Acta 2002; 1567: 23-33.
54. Ouyang M, Remy J, Szoka F Jr. Controlled template-assisted assembly of plasmid DNA into nanometric particles with high DNA oncentration. Bioconjug Chem 2000; 11: 104-112.
55. Dauty E, Remy J, Blessing T, et al. Dimerizable cationic detergents with a low cmc condense plasmid DNA into nanometric particles and transfect cells in culture. J Am Chem Soc 2001; 123: 9227-9234.
56. Schwartz B, Ivanov M, Pitard B, et al. Synthetic DNA-compacting peptides derived from human sequence enhance cationic lipid-mediated gene transfer in vitro and in vivo. Gene Ther 1999; 6: 282-292.
57. Drummond DC, Zignani M, Leroux J. Current status of pH-sensitive liposomes in drug delivery. Prog Lipid Res 2000; 39 409-460;
58. Kichler A, Mechtler K, Behr J, et al. Influence of membrane-active peptides on lipospermine/DNA complex mediated gene transfer. Bioconjug Chem 1997; 8: 213-221.
59. Tagawa T, Manwell M, Brown N, et al. Characterisation of LMD virus-like nanoparticles self-assembled from cationic liposomes, adenovirus core peptide mu and plasmid DNA. Gene Ther 2002; 9 564-576.
60. Hofland H, Shephard L, Sullivan S. Formation of stable cationic lipid/DNA complexes for gene transfer. Proc Natl Acad Sci U S A 1996; 93: 7305-7309.
61. Wheeler J, Palmer L, Ossanlou M, et al. Stabilized plasmid-lipid particles: construction and characterization. Gene Ther 1999; 6: 271-281.
62. Tam P, Monck M, Lee D, et al. Stabilized plasmid-lipid particles for systemic gene therapy. Gene Ther 2000; 7: 1867-1874.
63. Mok K, Lam A, Cullis P. Stabilized plasmid-lipid particles: factors influencing plasmid entrapment and transfection properties. Biochim Biophys Acta 1999; 1419: 137-150.
64. Hofland H, Nagy D, Liu J, et al. In vivo gene transfer by intravenous administration of stable cationic lipid/DNA complex. Pharm Res 1997; 14: 742-749.
65. Maurer N, Mori A, Palmer L, et al. Lipid-based systems for the intracellular delivery of genetic drugs. Mol Membr Biol 1999; 16: 129-140.
66. Johnstone S, Masin D, Mayer L, et al. Surface-associated serum proteins inhibit the uptake of phosphatidylserine and poly(ethylene glycol) liposomes by mouse macrophages. Biochim Biophys Acta 2001; 1513: 25-37.
67. Perouzel E, Jorgensen M, Keller M, et al. Synthesis and formulation of neoglycolipids for the functionalization of liposomes and lipoplexes. Bioconj Chem 2003; 14: 884-898.
68. Hofland H, Lamons L, Meng X. Neutral and anionic colloidal particles for gene delivery. US Patent 2000.
69. Bailey A, Sullivan S. Efficient encapsulation of DNA plasmids in small neutral liposomes induced by ethanol and calcium. Biochim Biophys Acta 2000; 1468: 239-252;
70. Herscovici J, Scherman D, Tranchant I, et al. Dérivés lipidiques de polythiourée. French Patent 2001.
71. Mignet N, Brun A, Degert C, et al. The spherulites (TM): a promising carrier for oligonucleotide delivery. Nucleic Acids Res 2000; 28: 3134-3142;
72. Pott T, Roux D. DNA intercalation in neutral multilamellar membranes. FEBS Lett 2002; 511: 150-154.
73. Nicolazzi C, Garinot M, Mignet N, et al. Cationic lipids for transfection. Curr Med Chem 2003; 10: 1263-1277.
74. Needham D, Stoicheva N, Zhelev D. Exchange of monooleoylphosphatidylcholine as monomer and micelle with membranes containing poly(ethylene glycol)-lipid. Biophys J 1997; 73: 2615-2629.
75. Song L, Ahkong Q, Rong Q, et al. Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes. Biochim Biophys Acta 2002; 1558: 1-13.
76. Nicolazzi C, Mignet N, de la Figuera N, et al. Anionic polyethyleneglycol lipids added to cationic lipoplexes increase their plasmatic circulation time. J Contr Rel 2003; 88: 429-443.
77. Shi F, Wasungu L, Nomden A, et al. Interference of polyethylene glycol-lipid analogues with cationic lipid-mediated delivery of oligonucleotides; roles of exchangeability and non-lamellar transitions. Biochem J 2002; 336: 333-341.
78. Krasnici S, Werner A, Eichhorn M, et al. Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels. Int J Cancer 2003; 105: 561-567.
79. Kirpotin D, Hong K, Mullah N, et al. Liposomes with detachable polymer coating: destabilization and fusion of dioleoylphosphatidylethanolamine vesicles triggered by cleavage of surface-grafted poly(ethylene glycol). FEBS Lett 1996; 388: 115-118.
80. Bessodes M, Masson C, Scherman D, et al. Acid-sensitive compounds for delivering drugs to the cells. PCT Int Appl March 14 2002; WO 020510: 73.
81. Hofland H, Masson C, Iginla S, et al. Folate-targeted gene transfer in vivo. Mol Ther 2002; 5: 739-744.
82. Janssen A, Schiffelers R, ten Hagen T, et al. Peptide-targeted PEG-liposomes in anti-angiogenic therapy. Int J Pharm 2003; 254: 55-58.
83. Hood J, Bednarski M, Frausto R, et al. Tumor regression by targeted gene delivery to the neovasculature. Science 2002; 296: 2404-2407.